[ Price : $8.95]
FDA grants Biovest International an orphan drug designation for BiovaxID for treating Waldenstrom's macroglobulinemia.[ Price : $8.95]
Gilead Sciences files an NDA for Quad, a single-tablet regimen of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil...[ Price : $8.95]
FDA says fewer NDA/ANDA bioanalytical studies will need to be repeated or confirmed based on earlier data integrity concerns at co...[ Price : $8.95]
FDA approves an Abbott supplemental NDA for Lupron Depot-PED (leuprolide acetate for depot suspension) to include long-term data i...[ Price : $8.95]
CDER says it is experiencing a big increase in the number of INDs it is receiving for botanical drugs compared with eight years ag...[ Price : $8.95]
Republican House Energy and Commerce Committee leaders ask FDA to explain why it apparently continues to allow two Chinese compani...[ Price : $8.95]
FDA clears a Stealth Therapeutics 510(k) for its Invisiport, an alternative to traditional chest ports and peripherally inserted c...[ Price : $8.95]
FDA says a proposed single clinical study would generate sufficient data to support approval of Adventrx Pharmaceuticals docetaxel...